Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

X4 Pharmaceuticals Announces $125M Capital Infusion From $105M Sale of Priority Review Voucher And $20M Drawdown from Existing Loan Facility, Extends Projected Cash Runway Into Late 2025

Author: Benzinga Newsdesk | May 09, 2024 07:23am

Posted In: XFOR